✦ LIBER ✦

OP009 Long-term safety and efficacy of golimumab in patients with moderately to severely active ulcerative colitis: Results from the PURSUIT-SC Maintenance study extension

✍ Scribed by Reinisch, W.; Gibson, P.; Sandborn, W.J.; Feagan, B.G.; Marano, C.; Strauss, R.; Johanns, J.; Zhang, H.; Padgett, L.; Colombel, J.-F.; Collins, J.; Rutgeerts, P.

Book ID: 122129973
Publisher: Oxford University Press
Year: 2014
Tongue: English
Weight: 65 KB
Volume: 8
Category: Article
ISSN: 1873-9946
DOI: 10.1016/S1873-9946(14)60010-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mo1214 Long-Term Safety and Efficacy of

Mo1214 Long-Term Safety and Efficacy of Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the PURSUIT-SC Maintenance Study Extension

✍ Gibson, Peter R.; Reinisch, Walter; Sandborn, William; Feagan, Brian G.; Marano, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 190 KB

943d A Phase 2/3 Randomized, Placebo-con

943d A Phase 2/3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Subcutaneous Golimumab Induction Therapy in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT SC

✍ W.J. Sandborn; B.G. Feagan; C.W. Marano; R. Strauss; J. Johanns; H. Zhang; J. Co 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Sa1203 Pharmacokinetics and Exposure-Res

Sa1203 Pharmacokinetics and Exposure-Response Relationship of Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Phase2/3 Induction and Maintenance Studies

✍ Adedokun, Omoniyi J.; Xu, Zhenhua; Marano, Colleen W; Strauss, Richard; Zhang, H 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 319 KB

P225 Impact of subcutaneously administer

P225 Impact of subcutaneously administered golimumab on disease specific and generic health-related quality of life in patients with moderately to severely active ulcerative colitis: Results from PURSUIT-SC induction

✍ Feagan, B.; Gibson, P.; Marano, C.; Strauss, R.; Han, C.; Johanns, J.; Zhang, H. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 120 KB

Long-term efficacy and safety of adalimu

Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL

✍ Kenneth Gordon; Kim Papp; Yves Poulin; Yihua Gu; Stephen Rozzo; Eric H. Sasso 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 347 KB

W1092 Maintenance of Long-Term Remission

W1092 Maintenance of Long-Term Remission in Patients with Moderately to Severely Active Crohn's Disease Treated for 3 Years with Adalimumab: Results from the Open-Label ADHERE Study

✍ Rutgeerts, Paul; Colombel, Jean-Frederic; Sandborn, William J.; Rutgeerts, Paul 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 99 KB